Lessons from Natural Simian Immunodeficiency Virus Infections of African Nonhuman Primate Hosts

Intervenant(s)

G. Silvestri

Événements

Lessons from Natural Simian Immunodeficiency Virus Infections of African Nonhuman Primate Hosts

MicroRNA Effectors to "Silence" HIV Replication

Toxoplasma Gondii and the Immunity-Related GTPase (IRG) Resistance Sytem

NKT Cells during Infection: From Viruses to Helminth

A New View of the Malaria Life Cycle

Developing versus Developed Countries: Differences in the Immune Response to BCG Vaccination

Towards a Universal Flu Vaccine

Vaccines against Chronic Infection: The Issue of CMV

Novel Viral Vaccines by Whole Genome Synthesis

Philippe Kourilsky, Philippe Sansonetti, A. Phalipon et F. Tangy

Round Table: Facing the Challenges of the Future

Voir aussi

Philippe Sansonetti, chaire Microbiologie et maladies infectieuses

Philippe Kourilsky, chaire Immunologie moléculaire

Vaccines of the Future: Learning from Nature to Identify New Targets and Do Better than Nature

Lessons from Natural Simian Immunodeficiency Virus Infections of African Nonhuman Primate Hosts

Intervenant(s)

G. Silvestri

Événements

Introduction

Vaccination throughout Centuries: From Empirism To "Omics"

Human Genetics and Innate Response

A Mouse Model for Studying Long-Term Memory

Immune Responses throughout Life Span: The Issue of Immunosenescence

Non-Conventional Antigens: CD1-Glycolipid Complexes

The Brucella Btp1 Effector and the Control of Dendritic Cell Maturation

Towards a Vaccine against AIDS: A Role of NK Cells

Lessons from Natural Simian Immunodeficiency Virus Infections of African Nonhuman Primate Hosts

MicroRNA Effectors to "Silence" HIV Replication

Toxoplasma Gondii and the Immunity-Related GTPase (IRG) Resistance Sytem

NKT Cells during Infection: From Viruses to Helminth

A New View of the Malaria Life Cycle

Developing versus Developed Countries: Differences in the Immune Response to BCG Vaccination

Towards a Universal Flu Vaccine

Vaccines against Chronic Infection: The Issue of CMV

Novel Viral Vaccines by Whole Genome Synthesis

Round Table: Facing the Challenges of the Future

Voir aussi